Delivery Order SPE2DB24D9223-SPE2DB25FKEKA
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on June 3, 2025. The delivery order, which carries an ultimate completion date of June 25, 2025, covers the supply of Stelara 90 mg/ml syringes for distribution to military healthcare facilities. This award was issued without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which is expected to be completed by September 3, 2025, covers the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare facilities. This award was issued without a set-aside designation, demonstrating the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on September 8, 2025. The delivery order, which has an ultimate completion date of September 29, 2025, is for Stelara 90 mg/ml syringes—a prescription biologic medication used to treat autoimmune and inflammatory conditions. This award was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which will be completed by September 3, 2025, covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This award carries no set-aside designation and represents a direct transaction under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for Stelara 90 mg/mL syringes. The award is issued under a firm fixed-price contract type with an ultimate completion date of August 28, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on September 11, 2025. The contract calls for the delivery of Stelara 90 mg/ml syringes, a biologic immunosuppressant medication used to treat autoimmune conditions. This is a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and no set-aside designation was...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $97,499.70 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. The award was issued without a set-aside designation, demonstrating the company's competitive strength in federal pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on September 8, 2025. The delivery order, issued under the SPE2DB Indefinite Delivery Contract (valued at $499,999,999 through November 2026), calls for the delivery of Stelara 90 mg/mL syringes to support Department of Defense healthcare facilities. The award carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order covers the supply of Stelara 90 mg/ml syringes, a biologic medication used to treat autoimmune conditions, with an ultimate completion date of September 22, 2025. This award was issued without a set-aside designation, allowing the...
- SPE2DB24D9223Indefinite Delivery Contract
- SPE2DB24D9223-SPE2DB25FKEKADelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 8, 2025. The delivery order covers Stelara 90 mg/mL syringes, a biologic immunosuppressant medication commonly used to treat autoimmune conditions. The award carries no set-aside designation, and the ultimate completion date is scheduled for August 29, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at approximately $500 million and remains valid through November 2026. DMS Pharmaceutical Group leverages its position as a critical supplier within the federal pharmaceutical supply chain to support the Department of Defense's healthcare operations nationwide. The company's SPE2DB contract enables the DLA to issue firm fixed-price delivery orders for an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables serving military health facilities. With a consistent track record of contract awards from the DLA since 2001, DMS Pharmaceutical Group has established itself as a reliable vendor for specialized pharmaceutical products including oncology treatments, vaccines, auto-injectors, and other specialty medications required by federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.5k | 8/8/25 |